In Bioethics and Racism: Practices, Conflicts, Negotiations and Struggles, Carlo Botrugno and his co-editors articulate how the marketization of healthcare transforms human life into an extractable resource. The commodification of healthcare occurs when life, bodily functions, and medical care are treated as tradeable goods regulated by market forces rather than fundamental human rights.
When healthcare shifts from a public good to a market commodity, it intersects with racial capitalism—a system where racial hierarchies are used to extract economic value, distribute risk, and justify unequal access to life-sustaining resources.
This systemic dynamic breaks down into four primary mechanisms:
1. Healthcare as a Tiered Market Commodity
Under neoliberal health models, high-quality medical care functions as a consumer product reserved for those with capital.
Differential Valuation of Life: Market logic dictates that resources flow toward profitable markets (e.g., lucrative elective procedures, chronic care management for affluent demographics, and high-margin pharmaceuticals).
Systemic Neglect: Low-income, racialized, and undocumented populations are constructed as "unprofitable" or "high-risk" consumers. Consequently, emergency care, public safety-net hospitals, and preventative services in marginalized communities are chronically underfunded or privatized, transferring fiscal burdens onto those least able to bear them.
2. Extraction, Bio-Capital, and Exploitation
The book examines how racialized bodies are often valorized primarily when their biological material, labor, or data can yield financial profit.
Clinical Trial Exploitation: Global biomedical research frequently relies on marginalized populations in the Global South or disadvantaged groups in the West for clinical trials. These groups absorb the biological risks of experimental treatments, but the resulting commercial therapies are often financially out of reach for the communities that helped test them.
Data and Genomic Extraction: Modern health tech and genomic platforms commodify population genetic data. The commercialization of health data frequently extracts value from racialized groups without returning structural health benefits, equitable access, or financial compensation to those communities.
3. Medical Deserts and Structural Abandonment
When market profitability governs clinical infrastructure, health institutions withdraw from areas that generate low financial returns.
Targeted Closures: Private healthcare networks regularly shutter safety-net hospitals, maternity wards, and trauma centers in predominantly racialized or low-income urban and rural zones, relocating facilities to affluent suburban markets.
Institutional Violence: Botrugno argues that this dynamic shifts health systems away from a duty of care toward a policy of structural abandonment, where preventable illness, higher maternal mortality rates, and reduced life expectancy become predictable economic outcomes rather than unexpected failures.
4. Epistemic Injustice and De-Humanization
The process of commodification alters the clinical encounter itself, transforming patients into administrative data points, billing codes, or profit vectors.
Depersonalization: Physicians and healthcare providers are constrained by productivity metrics (e.g., short appointment windows, volume-driven reimbursements), which discourages holistic patient engagement.
Compounded Vulnerability: For racialized and marginalized individuals, this depersonalization intersects with implicit bias and epistemic injustice. Their reports of pain, systemic distress, or environmental exposure are routinely dismissed, reducing complex socio-biological experiences to mere individual compliance or economic liabilities.
Summary Framework
Marketization of Health ──► Conversion of Care into Commodity
│
▼
Racial Capitalist Sorting ──► Profitable Bodies vs. "Unprofitable" Bodies
│
▼
Structural Outcomes ──► Data Extraction, Medical Deserts, & Tiered Survival
No comments:
Post a Comment